Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.
about
Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kineticsThe influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.An epichlorohydrin-crosslinked semi-interpenetrating GG-PEO network as a xerogel matrix for sustained release of sulpirideEffects of systemic ornidazole, systemic and local compound ornidazole and pefloxacin mesylate on experimental periodontitis in rats.Formulation Design and Development of a Unani Transdermal Patch for Antiemetic Therapy and Its Pharmaceutical EvaluationApplication and Characterization of Gum from Bombax buonopozense Calyxes as an Excipient in Tablet Formulation.Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers.The preparation of capsaicin-chitosan microspheres (CCMS) enteric coated tablets.Facile synthesis of magnetic-/pH-responsive hydrogel beads based on Fe3O4 nanoparticles and chitosan hydrogel as MTX carriers for controlled drug release.Formulation, in vitro evaluation and kinetic analysis of chitosan-gelatin bilayer muco-adhesive buccal patches of insulin nanoparticles.Localized rosuvastatin via implantable bioerodible sponge and its potential role in augmenting bone healing and regeneration.Formulation and evaluation of once daily minocycline hydrochloride extended release matrix tablets.Formulation and optimization of sustained release tablets of venlafaxine resinates using response surface methodology.Formulation and Evaluation of in situ Gels Containing Clotrimazole for Oral Candidiasis.Formulation and evaluation of a sustained-release tablets of metformin hydrochloride using hydrophilic synthetic and hydrophobic natural polymers.Preparation and evaluation of chitosan microspheres containing nicorandilChitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.Investigation of hydrogel membranes containing combination of gentamicin and dexamethasone for ocular delivery.Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniquesFormulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen.Formulation of controlled-release baclofen matrix tablets. II. Influence of some hydrophobic excipients on the release rate and in vitro evaluation.Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note.Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.Modulation of venlafaxine hydrochloride release from press coated matrix tablet.Design, development and permeation studies of nebivolol hydrochloride from novel matrix type transdermal patches.Effect of Kollidon® SR on the release of Albuterol Sulphate from matrix tablets.Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design.Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique.Fabrication and evaluation of captopril modified-release oral formulation.Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies.Development and evaluation of pulsatile drug delivery system using novel polymer.Formulation of controlled-release baclofen matrix tablets: Influence of some hydrophilic polymers on the release rate and in vitro evaluation.Poly(ethylene glycol)-co-methacrylamide-co-acrylic acid based nanogels for delivery of doxorubicin.Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate.Hydroxypropylcellulose-aceclofenac conjugates: high covalent loading design, structure characterization, nano-assemblies and thermal kineticsMacromolecular prodrugs of aspirin with HPMC: A nano particulate drug design, characterization, and pharmacokinetic studiesIn Situ Ophthalmic Gel of Ciprofloxacin Hydrochloride for Once a Day Sustained Delivery
P2860
Q24630908-9C5BF29E-09AA-439B-A194-082D351758AAQ31153207-0464173F-FA60-4E01-BD3E-B49F46908147Q34265163-F8816335-7232-4A2B-99FC-89CC888EA30AQ36577435-DE84EFA9-D9AD-4718-8821-505D11E507B7Q37049449-E7CB0CFB-BA73-4917-BE07-F531F0739905Q37327844-A55C51FF-476A-450D-83A3-E327A767D850Q37361033-E19633D2-F72F-4C38-9097-A5325A89C17AQ37420998-2136196C-AB9A-4492-B073-E827547B7F27Q38837261-5FE77986-3162-45DD-8708-B6453B0C4616Q39410919-AB08D8C7-8F00-4C11-84DD-260F10A8F4CCQ39948354-9C16E9D0-C841-4178-A395-FB267B7AF486Q40406178-4A464866-4B8B-4C9B-99A9-07638EDD8ADDQ40406953-565770D2-97DA-4E97-B49E-6A71FFD675E6Q40407102-1A05D34B-0930-4422-A811-98784A6FF5C9Q40695960-FF8EEC22-B8DA-497A-AFB7-B3AF3B90CA41Q41774604-D6B5F2A5-5C71-407F-8BE3-057D4D0E95CBQ41828709-7B57D3B4-5D6F-4F60-9B20-129763F1B907Q41832571-C4869181-1D8E-492A-B6ED-EA8C1E60D8C8Q41989390-AD6184D3-2C8F-4538-ACEF-E5094647E9D6Q41989518-4D9B3B77-953B-4F22-BDAF-2A8DB71BA9BCQ41989564-F126F91A-9AD0-44A2-AF7A-BE9F8733ED7EQ41990029-42A2BF4A-9A3B-4075-BD11-1C8478CC489BQ41990357-2CEFCDA2-A5A2-47A3-853C-0808E3CD0798Q42003505-37381D07-F2B6-4436-B9E8-3770750025C3Q42010770-D0B0212A-A584-405A-A75E-61CE6C78A4B0Q42035786-BB9F9162-5BC2-49B3-93F6-FD5EC5874880Q42291896-3E6491CC-0736-46EE-AFFA-314DE7B29D41Q42733027-E7C7FE60-38CB-453C-904D-AAD3F5082FA9Q42735733-772F9565-4BAF-4EA9-9FF2-D6998D431358Q43250323-7F39DAF9-8C6E-44F4-9FE6-692CCF08FA32Q45259769-32241725-189B-4147-92B0-9A137A7CF4B1Q46113193-7B257D2E-9299-456A-A53C-EC7669764DD9Q46714934-CEC23622-26C7-49F0-B249-C573DA70D540Q50616168-F3FC97C3-AB50-4C5B-8891-1F4F3F3C6829Q51453416-AD0C24D1-3209-463E-8BEE-0E2812E6A307Q57348127-B4FB37CA-8F03-4E8C-B735-6E8F71689C4BQ57353316-4AC27BA3-6131-48FE-82B6-0D3DA0B06C3FQ57378186-8C8B2264-C846-4F52-BE39-C05A3F7C8820
P2860
Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Once-daily sustained-release m ...... ation and in vitro evaluation.
@en
type
label
Once-daily sustained-release m ...... ation and in vitro evaluation.
@en
prefLabel
Once-daily sustained-release m ...... ation and in vitro evaluation.
@en
P2093
P2860
P356
P1433
P1476
Once-daily sustained-release m ...... ation and in vitro evaluation.
@en
P2093
K Raghuram Reddy
Srinivas Mutalik
Srinivas Reddy
P2860
P2888
P356
10.1208/PT040461
P407
P577
2003-12-12T00:00:00Z
P5875
P6179
1052565880